KANGHUI PHARMACEUTICAL released its first-quarter performance, reporting a net loss attributable to the parent of 17.2393 million yuan, turning from profit to loss

LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, KANGHUI PHARMACEUTICAL (603139.SH) released its first-quarter report for 2025. The company's first-quarter operating revenue was 121 million yuan, a year-on-year decrease of 4.72%; the net loss attributable to shareholders of the listed company was 17.2393 million yuan, turning from profit to loss; the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 18.4152 million yuan, with losses widening; the basic loss per share was 0.17 yuan/share

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.